hydrogen sulfide has been researched along with Colitis, Ulcerative in 24 studies
Hydrogen Sulfide: A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed)
hydrogen sulfide : A sulfur hydride consisting of a single sulfur atom bonded to two hydrogen atoms. A highly poisonous, flammable gas with a characteristic odour of rotten eggs, it is often produced by bacterial decomposition of organic matter in the absence of oxygen.
thiol : An organosulfur compound in which a thiol group, -SH, is attached to a carbon atom of any aliphatic or aromatic moiety.
Colitis, Ulcerative: Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Release of hydrogen sulfide when pouchitis was active (6." | 7.73 | Association between fecal hydrogen sulfide production and pouchitis. ( Furne, JK; Levitt, MD; Madoff, RD; Ohge, H; Rothenberger, DA; Springfield, J, 2005) |
| "Release of hydrogen sulfide when pouchitis was active (6." | 3.73 | Association between fecal hydrogen sulfide production and pouchitis. ( Furne, JK; Levitt, MD; Madoff, RD; Ohge, H; Rothenberger, DA; Springfield, J, 2005) |
| "Here we discuss two recent ulcerative colitis diet studies that illustrate this point." | 3.01 | Impact of diet on hydrogen sulfide production: implications for gut health. ( Biruete, A; Khoruts, A; Teigen, L, 2023) |
| "The aetiology of ulcerative colitis is uncertain but may relate to environmental factors in genetically predisposed individuals." | 2.45 | Sulphate-reducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis. ( Coffey, JC; Docherty, NG; O'Connell, PR; Rowan, FE, 2009) |
| "All controls and patients with active ulcerative colitis carried SRB and total viable counts were significantly related to the clinical severity grade." | 1.31 | The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. ( Beatty, ER; Cummings, JH; Pitcher, MC, 2000) |
| "The possible pathogenic role of HS- in ulcerative colitis was further investigated." | 1.31 | Hydrogen sulfide and colonic epithelial metabolism: implications for ulcerative colitis. ( Jørgensen, J; Mortensen, PB, 2001) |
| "Fecal samples from 25 subjects with ulcerative colitis and 17 controls were incubated in 4-L containers, and gas release was assessed at intervals over 24 h." | 1.30 | Fecal hydrogen sulfide production in ulcerative colitis. ( Ellis, CJ; Furne, JK; Levine, J; Levitt, MD; Springfield, J, 1998) |
| "Patients with ulcerative colitis were stratified by disease extent and activity, and by salicylate drug use." | 1.30 | Colonic luminal hydrogen sulfide is not elevated in ulcerative colitis. ( Babidge, W; Millard, S; Moore, J; Roediger, W, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (37.50) | 18.2507 |
| 2000's | 8 (33.33) | 29.6817 |
| 2010's | 3 (12.50) | 24.3611 |
| 2020's | 4 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, N | 1 |
| Lu, Y | 1 |
| Huang, Y | 1 |
| Zhang, Q | 1 |
| Tan, J | 1 |
| Zhang, J | 1 |
| Yao, M | 1 |
| Luo, G | 1 |
| Teigen, L | 1 |
| Biruete, A | 1 |
| Khoruts, A | 1 |
| Qin, CK | 1 |
| Yan, L | 1 |
| Wang, ZQ | 1 |
| Yu, G | 1 |
| Mao, GJ | 1 |
| Xu, F | 1 |
| Li, CY | 1 |
| Liu, Y | 1 |
| Liao, R | 1 |
| Qiang, Z | 1 |
| Yang, W | 1 |
| Cao, J | 1 |
| Zeng, H | 1 |
| Dryahina, K | 1 |
| Smith, D | 1 |
| Bortlík, M | 1 |
| Machková, N | 1 |
| Lukáš, M | 1 |
| Španěl, P | 1 |
| Sun, J | 1 |
| Shen, X | 1 |
| Li, Y | 1 |
| Guo, Z | 1 |
| Zhu, W | 1 |
| Zuo, L | 1 |
| Zhao, J | 1 |
| Gu, L | 1 |
| Gong, J | 1 |
| Li, J | 1 |
| Rowan, FE | 1 |
| Docherty, NG | 1 |
| Coffey, JC | 1 |
| O'Connell, PR | 1 |
| Blachier, F | 1 |
| Davila, AM | 1 |
| Mimoun, S | 1 |
| Benetti, PH | 1 |
| Atanasiu, C | 1 |
| Andriamihaja, M | 1 |
| Benamouzig, R | 1 |
| Bouillaud, F | 1 |
| Tomé, D | 1 |
| Tilg, H | 1 |
| Kaser, A | 1 |
| Ohge, H | 1 |
| Furne, JK | 3 |
| Springfield, J | 2 |
| Rothenberger, DA | 1 |
| Madoff, RD | 1 |
| Levitt, MD | 3 |
| Picton, R | 2 |
| Eggo, MC | 2 |
| Langman, MJ | 2 |
| Singh, S | 2 |
| Watanabe, K | 1 |
| Mikamo, H | 1 |
| Tanaka, K | 1 |
| Roediger, WE | 3 |
| Duncan, A | 1 |
| Kapaniris, O | 1 |
| Millard, S | 3 |
| Levine, J | 2 |
| Pitcher, MC | 2 |
| Cummings, JH | 2 |
| Moore, JW | 1 |
| Babidge, W | 3 |
| Rowland, R | 1 |
| Moore, J | 2 |
| Ellis, CJ | 1 |
| Roediger, W | 1 |
| Florin, T | 1 |
| Khalil, D | 1 |
| Lenarczyck, A | 1 |
| Moody, S | 1 |
| Cowley, D | 1 |
| Beatty, ER | 1 |
| Jørgensen, J | 1 |
| Mortensen, PB | 1 |
| Merrill, GA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Active Pouchitis[NCT00583076] | Phase 2 | 19 participants (Actual) | Interventional | 2007-02-28 | Completed | ||
| Antimicrobial Therapy for Ulcerative Colitis : Evaluation of Two Antibiotic Combinations for Refractory Ulcerative Colitis[NCT03986996] | Phase 2 | 20 participants (Actual) | Interventional | 2019-07-25 | Terminated (stopped due to There is no feasibility to conduct the study) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for hydrogen sulfide and Colitis, Ulcerative
| Article | Year |
|---|---|
Impact of diet on hydrogen sulfide production: implications for gut health.
Topics: Animals; Colitis, Ulcerative; Diet; Dietary Fiber; Dietary Proteins; Humans; Hydrogen Sulfide; Sulfi | 2023 |
Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease.
Topics: Animals; Colitis, Ulcerative; Crohn Disease; Disease Progression; Fatty Acid Synthases; Fatty Acids, | 2016 |
Sulphate-reducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis.
Topics: Amino Acids; Colitis, Ulcerative; Glutathione; Gram-Negative Bacterial Infections; Humans; Hydrogen | 2009 |
Luminal sulfide and large intestine mucosa: friend or foe?
Topics: Animals; Bacteria; Colitis, Ulcerative; Colon; Cystathionine gamma-Lyase; Energy Metabolism; Feces; | 2010 |
Diet and relapsing ulcerative colitis: take off the meat?
Topics: Butyrates; Colitis, Ulcerative; Diet; Humans; Hydrogen Sulfide; Meat; Probiotics; Recurrence | 2004 |
[Clinical significance of sulfate-reducing bacteria for ulcerative colitis].
Topics: Animals; Colitis, Ulcerative; Desulfotomaculum; Desulfovibrio; Humans; Hydrogen Sulfide; Intestinal | 2007 |
Hydrogen sulphide: a bacterial toxin in ulcerative colitis?
Topics: Bacterial Toxins; Colitis, Ulcerative; Desulfovibrio; Humans; Hydrogen Sulfide; Intestinal Mucosa | 1996 |
Colonic sulfide in pathogenesis and treatment of ulcerative colitis.
Topics: Bacteria; Colitis, Ulcerative; Colon; Humans; Hydrogen Sulfide; Methylation; Sulfides | 1997 |
16 other studies available for hydrogen sulfide and Colitis, Ulcerative
| Article | Year |
|---|---|
A novel fluorescent probe for real-time imaging of thionitrous acid under inflammatory and oxidative conditions.
Topics: Animals; Colitis, Ulcerative; Fluorescent Dyes; Hydrogen Sulfide; Mice; Oxidation-Reduction; Oxidati | 2022 |
A near-infrared fluorescent probe for detecting hydrogen sulfide with high selectivity in cells and ulcerative colitis in mice.
Topics: Animals; Colitis, Ulcerative; Fluorescent Dyes; HeLa Cells; Humans; Hydrogen Sulfide; Mice; Mitochon | 2023 |
Exogenous H
Topics: Animals; Autophagy; Cell Line; Colitis, Ulcerative; Cytokines; Humans; Hydrogen Sulfide; Male; NLR F | 2021 |
Pentane and other volatile organic compounds, including carboxylic acids, in the exhaled breath of patients with Crohn's disease and ulcerative colitis.
Topics: Acetic Acid; Adolescent; Adult; Aged; Biomarkers; Breath Tests; Butadienes; Carboxylic Acids; Coliti | 2017 |
Association between fecal hydrogen sulfide production and pouchitis.
Topics: Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Feces; Female; Humans; Hydrogen Sulfide; | 2005 |
Impaired detoxication of hydrogen sulfide in ulcerative colitis?
Topics: Adult; Colitis, Ulcerative; Crohn Disease; Erythrocytes; Female; Humans; Hydrogen Sulfide; Male; Met | 2007 |
Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis.
Topics: Colitis, Ulcerative; Colon; Fatty Acids; Glucose; Humans; Hydrogen Sulfide; In Vitro Techniques; Oxi | 1993 |
Ashkenazi Jews, sulfur gases, and ulcerative colitis.
Topics: Adolescent; Adult; Aged; Breath Tests; Colitis, Ulcerative; Colon; Humans; Hydrogen Sulfide; Jews; M | 1996 |
Hydrogen sulphide produces diminished fatty acid oxidation in the rat colon in vivo: implications for ulcerative colitis.
Topics: Animals; Colitis, Ulcerative; Colon; Epithelial Cells; Epithelium; Fatty Acids; Hydrogen Sulfide; In | 1997 |
Fecal hydrogen sulfide production in ulcerative colitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Carbon Dioxide; Carbon Monoxide; Chromatograph | 1998 |
Colonic luminal hydrogen sulfide is not elevated in ulcerative colitis.
Topics: Colitis, Ulcerative; Colon; Feces; Humans; Hydrogen Sulfide; Middle Aged; Spectrophotometry; Sulfide | 1998 |
Calming ulcerative colitis.
Topics: Bismuth; Colitis, Ulcerative; Humans; Hydrogen Sulfide; Organometallic Compounds; Salicylates | 1998 |
Re: Levine et al. Fecal hydrogen sulfide production in ulcerative colitis.
Topics: Animals; Colitis, Ulcerative; Feces; Humans; Hydrogen Sulfide; Rats | 1998 |
The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Dose-Response Relationship, Dru | 2000 |
Hydrogen sulfide and colonic epithelial metabolism: implications for ulcerative colitis.
Topics: Adult; Animals; Butyrates; Carbon Dioxide; Colitis, Ulcerative; Colon; Feces; Female; Humans; Hydrog | 2001 |
Mucosal protection against sulphide: importance of the enzyme rhodanese.
Topics: Adult; Aged; Aged, 80 and over; Colitis, Ulcerative; Dose-Response Relationship, Drug; Female; Human | 2002 |